MG-1121

N/A

Report date: 2025/06/11 11:03:53
NME

Base Information

Drug NameMG-1121
Drug Alias NameLong-Acting Factor VIII (GC Pharma/Mogam Institute for Biomedical Research)Long-Acting Factor VIII (Green Cross Corporation/Mogam Institute for Biomedical Research)MG-1121AMG-1121LAFATE
ClassificationSmall molecules
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMogam Biotechnology InstituteGC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A